Spero Therapeutics Announces Special Protocol Assessment Agreement with FDA for Phase 3 PIVOT-PO Trial of Tebipenem HBr streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
According to the most recent Future Market Insights (FMI) survey, the Knee Hyaluronic Acid Injections Market revenue will be $1.9 billion in 2021. Overall sales of knee hyaluronic acid injections are predicted to reach US$ 3.0 billion by 2031, expanding at a CAGR of more than 5.0% between 2021 and 2031.With surging.
Spero Therapeutics to Present Data at IDWeek 2022 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
The exclusive license allows GSK to commercialize tebipenem HBr in all territories, except Japan and certain other Asian countries Spero Therapeutics receives $66 million upfront, with potential for